Respironics Inc. Sustainability Profile
Respironics Inc., a leading name in the medical technology sector, is headquartered in the United States. Founded in 1976, the company has established itself as a pioneer in sleep and respiratory care, focusing on innovative solutions for patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (COPD). With a strong presence in North America and Europe, Respironics is renowned for its advanced CPAP devices, oxygen therapy systems, and sleep diagnostic tools. Their commitment to research and development has led to significant milestones, including the introduction of user-friendly interfaces and enhanced comfort features in their products. Recognised for its market leadership, Respironics continues to set industry standards, making a profound impact on patient care and quality of life.
DitchCarbon Score
How does Respironics Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Respironics Inc.'s score of 84 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Respironics Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is part of a corporate family that includes Koninklijke Philips N.V., from which it inherits emissions data and climate commitments. As a merged entity, Respironics Inc. aligns its climate initiatives with those of Koninklijke Philips N.V., which has set ambitious targets for reducing carbon emissions. However, specific reduction targets or achievements for Respironics Inc. have not been detailed. The company is involved in various sustainability initiatives, including participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Koninklijke Philips N.V. at a level 2 relationship. While no absolute emissions numbers are currently reported, Respironics Inc. is committed to addressing climate change through these inherited initiatives, reflecting a broader industry trend towards sustainability and carbon neutrality.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 449,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 717,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 991,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Respironics Inc.'s Industry?
How Carbon Intensive is Respironics Inc.'s Location?
Respironics Inc.'s Scope 3 Categories Breakdown
Respironics Inc.'s Scope 3 emissions, which decreased by 8% last year and increased by approximately 361% since 2007, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Respironics Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Respironics Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
